Press Releases

Filters (1)
January 13, 2016

Debiopharm International SA and EORTC announce a collaboration to investigate Triptorelin for treatment of Salivary Gland Cancers

Read more
January 11, 2016

Debiopharm International SA and Arbor Pharmaceuticals, LLC announce their US commercialization partnership for Triptorelin in Central Precocious Puberty

Read more
December 15, 2015

United Laboratories Inc. and Debiopharm International SA announce the launch of Pamorelin® LA in the Philippines

Read more
May 19, 2015

Debiopharm International SA Announces Phase III Positive Results for Triptorelin 6-month Formulation in the Management of Central Precocious Puberty (CPP)

Read more
September 30, 2014

Trelstar® Six-Month Dosing for Prostate Cancer Patients Launches in Canada

Read more
May 27, 2014

Orient EuroPharma and Debiopharm Group™ announce their partnership and the launch of Pamorelin LA in Singapore

Read more
January 13, 2014

Debiopharm Group™ Announces Completion of Recruitment for Phase III Clinical Study with Triptorelin 22.5 mg in Central Precocious Puberty

Read more
December 7, 2012

Dr. Reddy’s launches Debiopharm’s Pamorelin® LA in India for the treatment of locally advanced or metastatic, hormone-dependent prostate cancer

Read more
May 15, 2012

Debiopharm and Vifor Pharma sign an exclusive agreement for the distribution and commercialization of Pamorelin® LA in Switzerland – A…

Read more